Rivaroxaban in Tanzania: NEMLIT level, who can prescribe it and STG references
Rivaroxaban is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level S (zonal, special and national hospitals). It is not on the DukaDawa pharmacy network yet, so we show no brands or prices for it. The Standard Treatment Guidelines mention it in 8 or more sections.
Last updated
New to DukadawaRx? Register as a prescriber. Licensed prescribers only; we verify your registration before you can prescribe.
Is rivaroxaban available on the DukaDawa pharmacy network?
Not yet. Rivaroxaban is not in the DukaDawa network catalogue, so we have no brands, prices or stock for it.
Prescribers can still write it on a DukadawaRx prescription, and we show it here as soon as a network pharmacy lists it.
Is rivaroxaban on the NEMLIT, and who can prescribe it?
Yes. Rivaroxaban is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level S (zonal, special and national hospitals). At level S it may be prescribed by specialists.
- Level
- S (zonal, special and national hospitals)
- Category
- Medicines Affecting Coagulation (Medicines Affecting the Blood)
- Listed forms
- Tablet 15mg, 20mg
- Page
- NEMLIT, p. 17
| Level | Facility | Who may prescribe |
|---|---|---|
| A | Dispensary | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer, Assistant Clinical Officer |
| B | Health centre | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer |
| C | Council or district hospital | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer |
| D | Regional referral hospital | Specialist, Medical Officer, Dental Officer |
| S (listed) | Zonal, special and national hospitals | Specialist |
A medicine is listed from the lowest facility level where it should be available.
Where is rivaroxaban in the Standard Treatment Guidelines?
The Standard Treatment Guidelines (7th edition, 2026) mention rivaroxaban in 8 or more sections, most often section 3.3.1 Coagulation Disorders > Deep Vein Thrombosis (DVT) (p. 82). See the STG for treatment details.
- 3.3.1 Coagulation Disorders > Deep Vein Thrombosis (DVT), p. 82
- 20.9.2 Heart Failure > Acute Heart Failure (AHF) or Decompensated Acute Heart Failure (ADHF), p. 504
- 20.10 Chronic Heart Failure, p. 506
- 20.16.1.2 Cardiac Arrhythmias/ Dysrhythmias > Tachyarrhythmias > AV Junctional Re-Entry Tachycardias, p. 515
- 4.2.5 Viral Infections > COVID-19, p. 110
- 8.2.1 Initial Management of Stroke > Management of Acute Hemorrhagic Stroke, p. 175
- 8.2.3 Initial Management of Stroke > Initial management of Acute Ischemic Stroke, p. 178
- 18.12 Closed fractures, p. 459
Sections that mention Rivaroxaban, most mentions first. Positions only: see the STG for treatment details.
Related medicines
- ApixabanNEMLIT S · Not on the DukaDawa network yet
- EtamsylateNEMLIT C · Not on the DukaDawa network yet
- HeparinNEMLIT S · Not on the DukaDawa network yet
- Low molecular Weight HeparinNEMLIT D · Not on the DukaDawa network yet
- Phytomenadione (Vitamin K1)NEMLIT B · Not on the DukaDawa network yet
- Protamine sulfateNEMLIT B · Not on the DukaDawa network yet
- Tranexamic acidNEMLIT C · Not on the DukaDawa network yet
- Unfractionated HeparinNEMLIT C · Not on the DukaDawa network yet
Sources
- Standard Treatment Guidelines and National Essential Medicines List (STG/NEMLIT), 7th edition, 2026, Ministry of Health, United Republic of Tanzania
Page last updated
STG positions are section numbers and printed page numbers only.
This page supports licensed prescribers and pharmacists. It is not medical advice and does not replace the Standard Treatment Guidelines, the product information or professional judgement. Prices and stock change often: confirm with the pharmacy.